Usana Health Sciences
USNA
121 hedge funds and large institutions have $206M invested in Usana Health Sciences in 2025 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 41 increasing their positions, 54 reducing their positions, and 55 closing their positions.
12.67% less ownership
Funds ownership: 70.02% → 57.35% (-13%)
24% less repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 54
27% less funds holding
Funds holding: 165 → 121 (-44)
45% less capital invested
Capital invested by funds: $371M → $206M (-$166M)
68% less call options, than puts
Call options by funds: $92K | Put options by funds: $289K
78% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 55
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$12.1M |
| 2 |
Millennium Management
New York
|
+$5.2M |
| 3 |
D.E. Shaw & Co
New York
|
+$3.15M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$2.06M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$2.06M |
Top Sellers
| 1 |
SWGC
Summit Wealth Group (Colorado)
Colorado Springs,
Colorado
|
-$64.7M |
| 2 |
BlackRock
New York
|
-$14.2M |
| 3 |
State Street
Boston,
Massachusetts
|
-$3.91M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.79M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$2.51M |
USNA Hedge Fund Activity: Q4 2025 in Review
121 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q4 2025, worth a combined $206M — down 45% from $371M a quarter earlier.
Sellers outnumbered buyers: 55 funds closed out of USNA and 12 opened new positions — a net loss of 43 holders — while 54 trimmed existing stakes and 41 added.
The largest buyer was Nantahala Capital Management, opening a new position worth an estimated $12.1M. The largest seller was Summit Wealth Group (Colorado), exiting entirely with an estimated $64.7M sold.
- 121 institutional investors held Usana Health Sciences (USNA) as of Q4 2025, down from 165 in Q3 2025.
- Funds reported $206M of Usana Health Sciences stock for Q4 2025, down 45% quarter-over-quarter.
- 12 funds opened new Usana Health Sciences positions in Q4 2025 and 55 closed out, a net change of -43 holders.
- The largest Usana Health Sciences buyer in Q4 2025 was Nantahala Capital Management, an estimated $12.1M added.
- The largest Usana Health Sciences seller in Q4 2025 was Summit Wealth Group (Colorado), an estimated $64.7M sold.
Based on aggregated 13F filings for Q4 2025.